Why join us?
Parabilis Medicines is a highly distinctive young biopharmaceutical company whose intention is to grow over time into the ranks of major therapeutics companies. Our foundational platform of Helicon™ therapeutics are peptides capable of efficient cell entry and modulation of both protein-protein and protein-DNA interactions. Through Helicon therapeutics, Parabilis is poised to revolutionize the medical possibilities for patients by precisely drugging intracellular targets long understood to be significant drivers of disease but never before drugged due to the limitations of existing drug modalities to act within the cell.
An important distinctive element of Parabilis is our lead program FOG-001, the company’s first-in-class TCF-blocking β-catenin inhibitor. This compound is approximately 18 months and ~50 patients into our early development program for patients with advanced solid tumors, most importantly colorectal cancer. There are few products in the ecosystem with the medical and economic potential of FOG-001. Parabilis is fully leveraging the unprecedented potential Helicons present by deploying proprietary, custom-built machine learning and computational methods as part of its discovery and development process. Parabilis Medicines has raised more than $500 million to date from leading life sciences investors. Parabilis Medicines is headquartered in Cambridge, Mass.
What’s the opportunity?
This is an exciting opportunity to bring a transformational new modality, our Helicon degraders, to clinical development with first-in-class and best-in-class programs. We are seeking a creative drug designer, ideally with experience in targeted protein degradation or other induced proximity modalities. Helicons have the ability to bind tightly to a broad range of targets that traditionally are thought to be undruggable and this provides a unique opportunity to expand the accessible drug space by incorporating degrader and molecular glue functionalities. The successful candidate will be responsible for leading the molecular design on Helicon degrader programs from hit to development candidates. In addition, the candidate may have opportunities to lead program teams to deliver development candidates. Specifically:
What you will need to be successful in this role:
Core Values
Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.
As an equal opportunity employer, Parabilis Medicines values diversity and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.
30 Acorn Park Drive | Cambridge, MA 02140 | www.parabilismed.com
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Are you ready to join an innovative team at Parabilis Medicines as the Associate Director of Medicinal Chemistry, focusing on Helicon Degrader Design? Based in the vibrant city of Cambridge, this exciting role is perfect for those who are passionate about transforming the landscape of drug development. At Parabilis, we're on a mission to revolutionize therapeutics with our Helicon™ platform, which includes cutting-edge peptides that can unequivocally impact drug interactions within the cell. If you have a background in drug design and are familiar with targeted protein degradation methods, you'll find this opportunity incredibly rewarding. You'll be leading molecular design efforts and working collaboratively across various disciplines to advance our promising programs, such as FOG-001, our pioneering β-catenin inhibitor currently in clinical development. By leveraging state-of-the-art methods and a strong focus on innovation, you will drive our first-in-class Helicon degraders toward therapeutic realization. Join us in a fast-paced, collaborative environment where your expertise will make a tangible difference for patients dealing with advanced diseases. With over $500 million raised from leading life sciences investors, we're well-positioned to deliver transformative therapies. Take the lead in shaping drug discovery and play a pivotal role in advancing our mission at Parabilis Medicines!
Lead the establishment of the sterile drug product development function at Mammoth Biosciences, driving innovative mRNA therapeutics from concept to clinic.
Join Quandela as a Senior Quantum Information Scientist to leverage your expertise in quantum error correction for cutting-edge quantum computing solutions.
Join Zentiva as a Manager Biosimilars Analytics, where you'll lead analytical methods and quality control for innovative biosimilar products.
NTU is looking for a post-doctoral research fellow in Water Resources Engineering to support impactful research initiatives.
Peraton is looking for an experienced Image Scientist to enhance national security through advanced imaging technology.
Emory University invites applications for an Academic Research Scientist role to enhance pioneering research in the School of Medicine.
Subscribe to Rise newsletter